News
Discover the latest advancements in biosimilars, including tocilizumab's new indication, and partnerships for omalizumab and ...
The agreement is for Kashiv BioSciences’ biosimilar candidate to Genentech and Novartis AG’s Xolair (omalizumab) in the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback